Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S T Donta

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
American Journal of Hospital Pharmacy|November 1, 1980
Factors associated with creatinine clearance changes following gentamicin therapyR A Prince, M H Ling, C D Hepler, et al.
Controlled Clinical Trials|June 1, 2001
A multicenter two by two factorial trial of cognitive behavioral therapy and aerobic exercise for Gulf War veterans' illnesses: design of a veterans affairs cooperative study (CSP #470)P Guarino, P Peduzzi, S T Donta, et al.
The Journal of Infectious Diseases|September 1, 1996
Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study GroupS T Donta, P Peduzzi, A S Cross, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
American Journal of Hospital Pharmacy|November 1, 1980
Factors associated with creatinine clearance changes following gentamicin therapyR A Prince, M H Ling, C D Hepler, et al.
Controlled Clinical Trials|June 1, 2001
A multicenter two by two factorial trial of cognitive behavioral therapy and aerobic exercise for Gulf War veterans' illnesses: design of a veterans affairs cooperative study (CSP #470)P Guarino, P Peduzzi, S T Donta, et al.
The Journal of Infectious Diseases|September 1, 1996
Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study GroupS T Donta, P Peduzzi, A S Cross, et al.
Pageof 8